Phenotypic and genotypic detection of antimicrobial-resistant bacterial pathogens from patients with infectious keratitis in selected hospitals in Ilorin, Nigeria

*1Oladejo, O. J., 2Oladejo, J. M., 3Aina, A., 4Oladejo, P., 4Odetoyin, B., 2Oluwaloniola, V., and 2Tangkat, T.

1Department of Ophthalmology, LAUTECH Teaching Hospital, Ogbomoso, Nigeria

2Department of Microbiology and Parasitology, University of Ilorin Teaching Hospital, Ilorin, Nigeria

3Deparrment of Ophthalmology, Bowen University Teaching Hospital, Ogbomoso, Nigeria

4Department of Microbiology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria *Correspondence to: olawalejob4@gmail.com

Abstract:
Background: Infectious keratitis is a major cause of global blindness. Standard management approaches typically involve the collection of corneal cultures and initiation of broad-spectrum antimicrobials. However, conventional microbiological techniques, based on direct visualization or cultures of microorganisms, are limited by poor sensitivity and the prolonged time required to produce actionable results. Molecular methods based on nucleic acid amplification technique aim to circumvent the challenges of culture for hours or days. The objectives of this study are to detect the bacteria agents of infectious keratitis in Ilorin, Nigeria, using phenotypic and molecular methods, and to determine their resistance profiles to selected antimicrobials. Continue reading “Phenotypic and genotypic detection of antimicrobial-resistant bacterial pathogens from patients with infectious keratitis in selected hospitals in Ilorin, Nigeria”

Phenotypic and molecular identification of antimicrobial resistance in Escherichia coli and Salmonella species isolated from apparently healthy broilers and zoo birds in Cameroon

*1Nelly, Z. Z., 2Oladele, O. A., 3,4Djim-Adjim-Ngana, K., 4Mouliom, M. M. M., 4,5Dah, I., and 6Josiane, N. M. C.

1Avian Medicine Program, Pan African University Life and Earth Sciences Institute (Including Health and Agriculture), Ibadan, Nigeria

2Department of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria

3Centre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plant Studies, P. O. Box 13033, Yaounde, Cameroon

4Department of Veterinary Public Health, School of Veterinary Medicine and Sciences, University of Ngaoundere, P. O. Box 454 Ngaoundere, Cameroon

5National Veterinary Laboratory (LANAVET), P. O. Box 503 Garoua, Cameroon

6School of Veterinary Medicine and Sciences, The University of Ngaoundere, P. O. Box 454 Ngaoundere, Cameroon

*Correspondence to: zimbinelly93@gmail.com

Abstract:
Background: Knowledge of antimicrobial resistance patterns of bacteria in food and pet birds in our environment is a prerequisite to effective control of bacterial diseases in humans and other food animals. Particularly, there is a dearth of information on the prevalence of resistant bacteria in pet and zoo birds in Cameroon. This study was carried out to determine the antibiotic resistance profiles of Escherichia coli and Salmonella spp isolates in apparently healthy poultry and zoo birds in Cameroon and to phenotypically and genotypically identify extended-spectrum β-lactamases (ESBLs) isolates in the poultry and aviary birds. Continue reading “Phenotypic and molecular identification of antimicrobial resistance in Escherichia coli and Salmonella species isolated from apparently healthy broilers and zoo birds in Cameroon”

Antibiotic resistance profiles of uropathogenic bacterial isolates in Haut-Sassandra Region, Côte d’Ivoire from January 2019 to December 2022

 

[1]Gbégbé, D. A., 1,2N’zi, N. P., 3Monthaut, S., 2Guessennd-Kouadio, N., and *1Angaman, D. M.

1Department of Biochemistry-Microbiology, Jean Lorougnon Guédé University, Daloa, P.O. Box 150 Daloa, Côte d’Ivoire

2Department of Bacteriology-Virology, National Reference Center for Antibiotics, Pasteur Institute Côte d’Ivoire, P. O. Box 490 Abidjan 01, Côte d’Ivoire

3Bacteriology-Virology Laboratory, Regional Hospital Center of Daloa, P. O. Box 207 Daloa, Côte d’Ivoire *Correspondence to: angaman@ujlg.edu.ci

 

Abstract:

Background: The escalating issue of bacterial resistance is a profound universal peril. This looming crisis has evolved from a mere forecast to a tangible reality globally. Urinary tract infections (UTIs) significantly influence antibiotic prescriptions in primary care, thus crucially impacting the selective pressure and the emergence of antibiotic-resistant bacteria. A profound comprehension of the microorganisms involved in UTIs and their resistance patterns is crucial, particularly in Daloa city, Côte d’Ivoire. This research aims to review the antibiotic resistance profiles of uropathogens isolated from patients in the Regional Hospital Center (CHR) of Daloa, Côte d’Ivoire from January 2019 to December 2022. Continue reading “Antibiotic resistance profiles of uropathogenic bacterial isolates in Haut-Sassandra Region, Côte d’Ivoire from January 2019 to December 2022”

Faecal carriage of extended spectrum β-lactamase producing Enterobacterales (ESBL-PE) in children under five years of age at a tertiary hospital in southwest Nigeria

[1]Abayomi, S. A., 2Oladibu, O. T., 3Lawani, O. A., 4Owolabi, K. I., 2Alabi, A. O.,        and *2Onigbinde, M. O.

1Cancer Research UK, Swansea, Wales, United Kingdom

2Department of Paediatrics and Child Health, College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso, Nigeria

3Department of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Ilorin, Nigeria

42102 Cole Street, Dudley, West Midlands, United Kingdom                                         

*Correspondence to: moonigbinde@lautech.edu.ng

Abstract:  

Background:  The main reservoir of Enterobacterales is the human gut, which has been reported as a source of hospital acquired infection. Enterobacterales carrying the extended spectrum β-lactamase (ESBL) genes have emerged over the years as significant multidrug resistant (MDR) pathogens, that have hindered effective therapy of infections caused by them, and limited treatment to a small number of drugs such as carbapenems, leading to selection pressure and emergent resistance to carbapenems. The objective of this study was to determine the faecal carriage of ESBL-producing Enterobacterales (ESPL-PE) among children under 5 years of age at the Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso, Nigeria.    Continue reading “Faecal carriage of extended spectrum β-lactamase producing Enterobacterales (ESBL-PE) in children under five years of age at a tertiary hospital in southwest Nigeria”

High faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE) among hospitalized patients at Sylvanus Olympio Teaching Hospital, Lomé, Togo in 2019

*1,2Godonou, A. M., 2Lack, F., 3,4Gbeasor-Komlanvi, F. A., 2Konlani, L., 2,3Dossim, S., 1Ameyapoh, Y. A., 3,4Ekouevi, K., 2,3Dagnra, A. Y., and 3,5Salou, M.

1High School of Biological and Food Technics, University of Lomé, Togo

2Teaching Hospital Sylvanus Olympio, Lomé, Togo

3Faculty of Health Sciences, University of Lomé, Togo

4Faculty of Health Sciences Public Heath Department, University of Lomé, Togo

5Teaching Hospital Campus, Lomé, Togo *Correspondence to: godonouvirginie@yahoo.fr

Abstract:
Background: Extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE) are a global health concern, associated with increased morbidity and mortality. Even in the absence of infections, colonization by these pathogens is still a great threat because of the risk of cross transfer among hospitalized patients. Faecal carriage of ESBL-PE remained poorly documented in Africa. This study aimed to determine faecal carriage rate of ESBL-PE, factors associated with carriage, and antimicrobial susceptibility of the strains among hospitalized patients at Sylvanus Olympio Teaching Hospitals (CHU SO) in Lomé, Togo. Continue reading “High faecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE) among hospitalized patients at Sylvanus Olympio Teaching Hospital, Lomé, Togo in 2019”

Microbial contamination of Naira notes circulating in Bauchi metropolis: prevalence, microbial load and detection of extended spectrum beta-lactamase producing  Gram-negative bacteria

1Usman, M.,2Sani J.,3Ibrahim, A., and *4Olowo-okere, A  

1Department of Pharmacy, Nigerian Air Force Reference Hospital, Bauchi, Nigeria

2Department of Clinical Pharmacy, Kaduna State University, Kaduna, Nigeria     

3Department of Medical Microbiology, Abubakar Tafawa Balewa Teaching Hospital, Bauchi, Nigeria

4Department of Pharmaceutics and Pharmaceutical Microbiology, Usmanu Danfodiyo University, Sokoto, Nigeria *Correspondence to: olowoahmed@gmail.com

Abstract:

 Background: Globally, contamination of banknotes with various microbial species is increasingly being reported. This usually results from improper handling during exchange of goods and services. In the present study, we aimed to determine the microbial load, prevalence and the presence of Extended Spectrum Beta Lactamase (ESBL) among bacteria isolated from the Nigerian Naira notes circulating in Bauchi metropolis.

Methodology: A total of 400 Naira notes of various denominations were randomly collected aseptically, cultured and total viable counts determined. The isolated microbial species were identified using standard microbiological techniques. Antibiotic susceptibility of the isolates and detection of ESBL were determined by Kirby-Bauer’s disc diffusion method and Double Disc Synergy Test (DDST), respectively. Continue reading “Microbial contamination of Naira notes circulating in Bauchi metropolis: prevalence, microbial load and detection of extended spectrum beta-lactamase producing  Gram-negative bacteria”

Prevalence and factors associated with extended-spectrum β-lactamase producing Enterobacteriaceae bacteraemia in University Hospital of Befelatanana, Madagascar

*1Rakotovao-Ravahatra Z. D., 2Randriatsarafara, F. M., 3Rakotovao, A. L., and 3Rasamindrakotroka, A.

1Laboratory of Joseph Raseta Befelatanana, University Hospital, Antananarivo, Madagascar

2Public Health Department, Faculty of Medicine, University of Antananarivo, Madagascar

3Medical Biology Department, Faculty of Medicine, University of Antananarivo, Madagascar *Correspondence to: ravahatradomoina@yahoo.fr; +261 34 09 301 20

Abstract:
Background: The extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae are a major cause of nosocomial bacteraemia. The objectives of this study are to describe the antibiotic resistance pattern of ESBL producing Enterobacteriaceae responsible for bacteraemia and identify factors associated with these infections in a University Hospital in Madagascar. Continue reading “Prevalence and factors associated with extended-spectrum β-lactamase producing Enterobacteriaceae bacteraemia in University Hospital of Befelatanana, Madagascar”

Laboratory survey of extended spectrum beta-lactamase producing Enterobacteriaceae from selected tertiary hospitals in south-eastern Nigeria

*1Ugah, U. I., and 2Udeani, T. K.

1Department of Microbiology, Faculty of Science, Alex Ekwueme Federal University, Ndufu-Alike 2Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, University of Nigeria, Enugu Campus *Correspondence to: uchenna.ugah@funai.edu.ng; +2347062154353

Abstract:

Background: Extended spectrum beta-lactamases are produced by Gram-negative bacteria and most strains producing them belong to the family Enterobacteriaceae. The greatest challenge with ESBL-producing Enterobacteriaceae is their propensity to acquire multidrug resistance traits. This study aimed at determining the prevalence of ESBL-producing Enterobacteriaceae among selected tertiary hospitals in south-eastern Nigeria.

Methods: A total of 400 Enterobacteriaceae isolates were obtained from patients attending five selected tertiary hospitals and were identified to species level by Gram staining and conventional biochemical tests. Screening for ESBL production was determined by the Kirby-Bauer disk diffusion method using 30μg disk of ceftriaxone, cefuroxime, cefpodoxime, ceftazidime, and aztreonam while confirmatory test was done using combination disk test based on the 2016 CLSI guidelines.

Results: The prevalence of ESBL production among Enterobacteriaceae isolates from selected hospitals in southeast Nigeria is 61.5% (246 of 400). Among the isolates obtained, the highest prevalence was observed in Klebsiella oxytoca (100%) while the least prevalence was seen in Morganella morganii (50.0%). Escherichia coli and Klebsiella pneumoniae had rates of 61.8% and 62.3% respectively. Among the States of the south-east Nigeria, selected hospital in Ebonyi had a prevalence of 83.5%, Abia 63.6%, Anambra 61.5%, Enugu 51.7% and Imo 36.5%. The prevalence of ESBL-producing Enterobacteriaceae differ significantly between the States (p=0.000).

Conclusion: ESBL-producing Enterobacteriaceae strains have been isolated from different participants, from the selected tertiary hospitals in south-eastern Nigeria. Therefore, we report a high prevalence of ESBL-producing Enterobacteriaceae in south-eastern Nigeria.

Keywords: ESBL, Enterobacteriaceae, resistant strains, southeast Nigeria

Received Feb 12, 2020; Revised March 27, 2020; Accepted March 28, 2020

Copyright 2020 AJCEM Open Access. This article is licensed and distributed under the terms of the Creative Commons Attrition 4.0 International License <a rel=”license” href=”//creativecommons.org/licenses/by/4.0/”, which permits unrestricted use, distribution and reproduction in any medium, provided credit is given to the original author(s) and the source.

Enquête en laboratoire sur les entérobactéries productrices de bêta-lactamases à spectre étendu de certains hôpitaux tertiaires du sud-est du Nigéria

*1Ugah, U. I., et 2Udeani, T. K. Continue reading “Laboratory survey of extended spectrum beta-lactamase producing Enterobacteriaceae from selected tertiary hospitals in south-eastern Nigeria”

Laboratory survey of extended spectrum beta-lactamase producing enterobacteriaceae in clinical infections among hospitalised patients at LAUTECH Teaching Hospital, Ogbomoso, Nigeria

*Abayomi, S. A., Adegboro, B., and Taiwo, S. S.
Department of Medical Microbiology and Parasitology, Ladoke Akintola University of Technology (LAUTECH) Teaching Hospital, PMB 4007, Ogbomoso, Nigeria *Correspondence to: subslaabayomi@gmail.com

Abstract:

Background: The extended-spectrum beta-lactamase (ESBL) producing enterobacteriaceae are a major public health threat globally, causing both community and healthcare associated infections (HAIs). Due to multi-resistant nature of these strains, infections caused by them are associated with treatment failure, high mortality, and increased healthcare costs. This laboratory survey determined the prevalence of infections caused by ESBL-producing enterobacteriaceae in LAUTECH Teaching Hospital, Ogbomoso Methodology: Over three years (January 2016 to December 2018), non-duplicate clinical samples (sputum, blood, urine, and wound swabs) collected from hospitalised patients with suspected clinical infections were routinely processed at microbiology laboratory of our hospital for aerobic culture and isolation of enterobacteriaceae. Antibiotic susceptibility of each isolate to routinely used antibiotics was determined by the disk diffusion method and ‘double disk’ synergy test was used to routinely confirm ESBL production. Demographic and clinical data were extracted from the requisition form. Results: Of the total 4,198 hospitalised patients over the three year period, 1,222 (29.1%) had clinical infections, out of which 689 (16.4%) were laboratory confirmed. Enterobacteriaceae were isolated from 343 patients (prevalence rate, 8.2%) while ESBL producers were isolated from 46 (prevalence rate, 1.1%). The most frequent enterobacteriaceae were Klebsiella spp (54.5%) and Escherichia coli (35.9%) recovered mainly from urinary tract infection (UTI, 45.2%), skin and soft tissue infection (SSTI, 27.9%) and lower respiratory tract infection (LRTI, 17.5%) but ESBL producers were frequently associated with osteomyelitis (50%), LRTI (18.3%) and SSTI (14.6%). The ESBL producers were all resistant to ampicillin, cefotaxime, ceftazidime, cefepime, gentamicin, and ciprofloxacin but susceptible to imipenem. The non-ESBL producers were comparatively less resistant with 43.8%, 34.3%, 29%, 35%, 43%, 37%, and 4% resistant to ampicillin, cefotaxime, ceftazidime, cefepime, gentamicin, ciprofloxacin and imipenem respectively. Conclusion: The prevalence of clinical infections among hospitalised patients in our facility is high but the rate of ESBL-producing enterobacteriaceae is relatively low. In spite of this, there is need for continuous surveillance of ESBL and other antibiotic resistant pathogens as part of the infection prevention and control (IPC) programme, with implementation of measures that will reduce the incidence of these infections in our hospital.

Keywords: Laboratory survey, hospitalised patients, ESBL, multidrug resistance
Received Sept 4, 2019; Revised September 20, 2019; Accepted September 21, 2019
Copyright 2020 AJCEM Open Access. This article is licensed and distributed under the terms of the Creative Commons Attrition 4.0 International License (//creativecommmons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium, provided credit is given to the original author(s) and the source.
Enquête de laboratoire sur les entérobactéries productrices de bêta-lactamases à spectre étendu lors d’infections cliniques chez des patients hospitalisés à l’hôpital universitaire LAUTECH, à Ogbomoso, au Nigéria
*Abayomi, S. A., Adegboro, B., et Taiwo, S. S.

Laboratory survey of ESBL-producing enterobacteriaceae Afr. J. Clin. Exper. Microbiol. 2020; 21(1): 66-71

Département de microbiologie médicale et de parasitologie, Hôpital universitaire de l’Université technique de Ladoke Akintola (LAUTECH), PMB 4007, Ogbomoso, Nigéria *Correspondance à: subslaabayomi@gmail.com

Abstrait:
Contexte: Les entérobactéries productrices de bêta-lactamase à spectre étendu (BLSE) constituent une menace majeure pour la santé publique dans le monde, provoquant à la fois des infections dans la communauté et des infections associées aux soins de santé. En raison de la nature multirésistante de ces souches, les infections qu’elles provoquent sont associées à un échec du traitement, à une mortalité élevée et à une augmentation des coûts de soins de santé. Cette enquête en laboratoire a permis de déterminer la prévalence d’infections causées par des entérobactéries productrices de BLSE à l’hôpital universitaire LAUTECH, à Ogbomoso. Méthodologie: Sur trois ans (janvier 2016 à décembre 2018), des échantillons cliniques non dupliqués (expectorations, sang, urine, et plaies oreilles) prélevés chez des patients hospitalisés présentant des suspicions d’infections cliniques ont été systématiquement traités dans le laboratoire de microbiologie de notre hôpital pour culture aérobie et isolement d’entérobactériacées. La sensibilité aux antibiotiques de chaque isolat aux antibiotiques utilisés en routine a été déterminée par la méthode de diffusion sur disque et un test de synergie «double disque» a été utilisé pour confirmer en routine la production de BLSE. Les données démographiques et cliniques ont été extraites du formulaire de demande. Résultats: Sur un total de 4198 patients hospitalisés au cours de la période de trois ans, 1222 (29,1%) ont présenté une infection clinique, dont 689 (16,4%) ont été confirmés en laboratoire. Des entérobactéries ont été isolées chez 343 patients (taux de prévalence de 8,2%), tandis que les producteurs de BLSE ont été isolés chez 46 patients (taux de prévalence de 1,1%). Les entérobactériacées les plus fréquentes étaient Klebsiella spp (54,5%) et Escherichia coli (35,9%) principalement dues à une infection des voies urinaires (UTI, 45,2%), une infection de la peau et des tissus mous (SSTI, 27,9%) et des voies respiratoires inférieures (LRTI, 17,5%), mais les producteurs de BLSE étaient fréquemment associés à l’ostéomyélite (50%), au LRTI (18,3%) et au SSTI (14,6%). Les producteurs de BLSE étaient tous résistants à l’ampicilline, au céfotaxime, à la ceftazidime, au céfépime, à la gentamicine et à la ciprofloxacine, mais sensibles à l’imipénem. Les producteurs non BLSE étaient comparativement moins résistants, avec respectivement 43,8%, 34,3%, 29%, 35%, 43%, 37% et 4% de résistance à l’ampicilline, au céfotaxime, au ceftazidime, au céfépime, à la gentamicine, à la ciprofloxacine et à l’imipénème. Conclusion: La prévalence d’infections cliniques chez les patients hospitalisés dans notre établissement est élevée mais le taux d’entérobactéries productrices de BLSE est relativement faible. Malgré cela, il est nécessaire de surveiller en permanence les BLSE et les autres agents pathogènes résistants aux antibiotiques dans le cadre du programme de prévention et de contrôle des infections (IPC), avec la mise en oeuvre de mesures permettant de réduire l’incidence de ces infections dans notre hôpital.

Mots clés: Enquête de laboratoire, patients hospitalisés, BLSE, résistance, multiple aux médicaments

Download full journal in PDF below

Laboratory survey of extended spectrum beta-lactamase producing enterobacteriaceae in clinical infections among hospitalised patients at LAUTECH Teaching Hospital, Ogbomoso, Nigeria

Prevalence and antibiotic resistance profiles of extended spectrum β-lactamase-producing Escherichia coli among paediatric patients with urinary tract infection in St. Patricks’ Hospital, Mile Four, Abakaliki, Ebonyi State, Nigeria

Iroha, I. R., Onyia, U., *Moses, I. B., Ejikeugwu, C. P., Nwakaeze, A. E., and Ugbo, E. N.
Department of Applied Microbiology, Faculty of Sciences, Ebonyi State University, Abakaliki, Nigeria *Correspondence to: ben_iyke70@yahoo.com

Abstract:
Background: The extended spectrum beta-lactamase (ESBL)-producing Escherichia coli strains which have been implicated in septicaemia among hospitalized children is a serious concern due to their high resistance rates to commonly used antimicrobial agents. The objective of this study was to determine the prevalence and antibiotic susceptibility of urinary ESBL-producing E. coli in paediatric patients who had clinical evidence of urinary tract infections (UTI). Methodology: Clean catch specimens of urine collected from 100 eligible paediatric patients with clinical evidence of UTI in St. Patricks’ Hospital, Mile Four, Abakaliki, Ebonyi State, were cultured for isolation of E. coli using standard bacteriological techniques. Isolates were confirmed for ESBL production by double disk synergy test (DDST), and antibiotic susceptibility of the ESBL-producing ones was determined by the modified Kirby Bauer disk diffusion method. Results: Twenty one (21%) E. coli were isolated out of which 11 (52 %) were ESBL producers, all of which were totally resistant (100%) to cefotaxime, ticarcillin and sulfamethoxazole-trimethoprim, 85% to aztreonam and 83% to ceftazidime. The multiple antibiotic resistance index (MARI) values ranged from 0.4 to 0.9, which implies high usage of antimicrobials Conclusion: The high prevalence of multi-drug resistant ESBL-producing E. coli obtained in this study shows that there has been overuse (abuse or misuse) of antibiotics in the study area. There is need for antimicrobial stewardship programme that will ensure prudent use of antimicrobial agents to forestall the emergence and spread of multi-drug resistant bacteria.

Keywords: Paediatrics, Escherichia coli, ESBL, urine, multi-drug resistance

Received February 8, 2019; Revised May 23, 2019; Accepted May 24, 2019
Copyright 2019 AJCEM Open Access. This article is licensed and distributed under the terms of the Creative Commons Attrition 4.0 International License (//creativecommmons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium, provided credit is given to the original author(s) and the source.

Profils de prévalence et de résistance aux antibiotiques d’Escherichia coli produisant des β-lactamases à spectre étendu chez des patients pédiatriques présentant une infection des voies urinaires à l’hôpital St. Patricks, Mile Four, Abakaliki, État d’Ebonyi, Nigéria

Iroha, I. R., Onyia, U. * Moses, I. B., Ejikeugwu, C. P., Nwakaeze, A. E., et Ugbo, E. N.
Département de microbiologie appliquée, Faculté des sciences, Université d’Ebonyi, Abakaliki, Nigéria *Correspondance à: ben_iyke70@yahoo.com

Abstrait:
Contexte: Les souches d’Escherichia coli productrices de bêta-lactamase à spectre étendu (BLSE) qui ont été impliquées dans la septicémie chez les enfants hospitalisés constituent un grave problème en raison de leur taux de résistance élevé aux agents antimicrobiens couramment utilisés. L’objectif de cette étude était de déterminer la prévalence et la sensibilité aux antibiotiques d’E. coli producteurs de BLSE dans l’urine chez les patients pédiatriques présentant des signes cliniques d’infections des voies urinaires (UTI). Méthodologie: Des échantillons d’urine prélevés chez 100 patients pédiatriques éligibles présentant des signes cliniques d’UTI à l’hôpital St. Patricks, à Mile Four, à Abakaliki, dans l’État d’Ebonyi, ont été cultivés pour l’isolement de E. coli à l’aide de techniques bactériologiques classiques. Les isolats ont été confirmés pour la production de BLSE par un test de synergie à double disque (DDST) et la sensibilité aux antibiotiques des producteurs de BLSE a été déterminée par la méthode de diffusion sur disque de Kirby Bauer modifiée. Résultats: Vingt et un (21%) E. coli ont été isolés, dont 11 (52%) étaient des producteurs de BLSE, qui étaient tous totalement résistants (100%) au céfotaxime, à la ticarcilline et au sulfaméthoxazole-triméthoprime, 85% à l’aztréonam et au 83 % en ceftazidime. Les valeurs de l’indice de résistance multiple aux antibiotiques (MARI) allaient de 0,4 à 0,9, ce qui implique une utilisation élevée d’antimicrobiens Conclusion: La prévalence élevée d’E. coli productrice de BLSE résistante à plusieurs médicaments obtenue dans cette étude montre qu’il y a eu surutilisation (abus ou abus). ) d’antibiotiques dans la zone d’étude. Un programme de gestion des antimicrobiens est nécessaire pour garantir une utilisation prudente des agents antimicrobiens afin de prévenir l’émergence et la propagation de bactéries multirésistantes aux médicaments

Mots-clés: pédiatrie, Escherichia coli, BLSE, urine, multirésistance

Download full journal in PDF below

Prevalence and antibiotic resistance profiles of extended spectrum β-lactamase-producing Escherichia coli among paediatric patients with urinary tract infection in St. Patricks’ Hospital, Mile Four, Abakaliki, Ebonyi State, Nigeria